Newly Diagnosed and Relapsed Follicular Lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Published in 2020 – Ann Oncol (2020)
Authors: M. Dreyling, M. Ghielmini, S. Rule, G. Salles, M. Ladetto, S. H. Tonino, K. Herfarth, J.F. Seymour & M. Jerkeman, on behalf of the ESMO Guidelines Committee
Follicular lymphomas are the second most frequent subtype of nodal lymphoid malignancies in Western Europe. The annual incidence of this disease is rare but has increased during recent decades. The updated ESMO Clinical Practice Guidelines on newly diagnosed and relapsed follicular lymphoma cover diagnosis, staging and risk assessment, treatment recommendations, innovative approaches, personalised medicine, follow-up and long-term implications and survivorship.
These Clinical Practice Guidelines are endorsed by the European Hematology Association (EHA)